EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MCID, SCB, and PASS Thresholds After Percutaneous Trigger Finger Release With or Without Corticosteroid Injection

Recep Karasu, Mustafa Dinç iD, Gökay Eken iD

Journal of Clinical Medicine · 14.08.2026 · 15 (16) · 6299

DOI: 10.3390/jcm15166299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.08.2026. Verfasst von Recep Karasu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Traumatology, Bursa City Hospital, Bursa 16250, Turkey. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Percutaneous A1 pulley release effectively treats trigger finger, but the additional benefit of concomitant corticosteroid injection remains debated. Moreover, minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) thresholds have not been well established for this procedure, limiting patient-centered interpretation of outcomes.

Methods

This retrospective cohort study included 80 patients (40 per group) who underwent percutaneous trigger finger release alone (PR) or with adjunctive triamcinolone injection (PR+CS). Anchor-based MCID and SCB thresholds for QuickDASH (Quick Disabilities of the Arm, Shoulder and Hand), Michigan Hand Outcomes Questionnaire (MHQ), and visual analog scale (VAS) pain were derived using GROC as the external anchor, whereas PASS thresholds were derived using a dichotomous acceptable-state question; ROC analysis was used for all threshold estimates. Group comparisons incorporated effect sizes and responder analyses.

Results

MCID thresholds were ΔVAS ≥ 3, ΔQuickDASH ≥ 19, and ΔMHQ ≥ 16.5; SCB thresholds were ΔVAS ≥ 4, ΔQuickDASH ≥ 25, and ΔMHQ ≥ 20; and PASS thresholds were 3-month VAS ≤ 4, QuickDASH ≤ 29, and MHQ ≥ 76. For MCID and SCB, MHQ showed the highest observed AUCs (0.899 and 0.946, respectively). Greater mean improvements in all change scores were observed in the PR+CS group than in the PR group (ΔQuickDASH 24.2 vs. 19.9, p < 0.001, d = 1.39; ΔMHQ 20.5 vs. 15.0, p < 0.001, d = 1.67). However, the magnitudes of the between-group differences did not reach the derived MCID or SCB thresholds. PASS achievement was numerically higher in the PR+CS group than in the PR group (75% vs. 55%), but this difference did not reach statistical significance (p = 0.061).

Conclusions

Preliminary MCID, SCB, and PASS estimates were derived for percutaneous trigger finger release; the principal novelty lies in the procedure-specific SCB and PASS estimates, with the SCB estimates being, to our knowledge, the first reported for any trigger finger treatment modality. MHQ showed the highest observed AUCs for MCID and SCB, whereas QuickDASH showed the highest observed AUC for PASS, underscoring the complementary information provided by the three instruments. Although greater mean functional changes were observed in the PR+CS group, the magnitudes of the between-group differences did not reach the derived MCID or SCB thresholds. However, given the retrospective, non-randomized design, these between-group findings remain exploratory and hypothesis-generating and should be viewed as a patient-centered re-interpretation of an established clinical question rather than as new comparative evidence; no causal benefit of adjunctive corticosteroid injection can be inferred. Given the small anchor-defined derivation subgroups and the potential instability of the selected cut-offs, these candidate estimates require prospective external validation in independent cohorts before clinical application.

Schlagwörter

Stichwörter der Autor:innen

Michigan Hand Outcomes Questionnairecorticosteroidminimal clinically important differencepatient acceptable symptom statepatient-reported outcome measurespercutaneous releasesubstantial clinical benefittrigger finger

Autor:innen und Institutionen

  • Department of Orthopedics and Traumatology, Bursa City Hospital, Bursa 16250, Turkey.
  • Hand Surgery Division, Department of Orthopaedics and Traumatology, Faculty of Medicine, Bursa Uludağ University, Bursa 16059, Turkey.

ORCID-Profile: Mustafa Dinç, Gökay Eken

Zitieren

APA

Karasu, R., Dinç, M., & Eken, G. (2026). MCID, SCB, and PASS Thresholds After Percutaneous Trigger Finger Release With or Without Corticosteroid Injection. Journal of Clinical Medicine, 15(16), 6299. https://doi.org/10.3390/jcm15166299

Vancouver

Karasu R, Dinç M, Eken G. MCID, SCB, and PASS Thresholds After Percutaneous Trigger Finger Release With or Without Corticosteroid Injection. Journal of Clinical Medicine. 2026;15(16):6299. doi:10.3390/jcm15166299

BibTeX
@article{Karasu2026,
  author = {Karasu, Recep and Dinç, Mustafa and Eken, Gökay},
  title = {MCID, SCB, and PASS Thresholds After Percutaneous Trigger Finger Release With or Without Corticosteroid Injection},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {16},
  pages = {6299},
  doi = {10.3390/jcm15166299}
}
Kostenlos starten →